XBIO vs VTVT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

XBIO

33.8
AI Score
VS
VTVT Wins

VTVT

50.8
AI Score

Investment Advisor Scores

XBIO

34score
Recommendation
SELL

VTVT

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XBIO VTVT Winner
Revenue 36.84M 1.47M VTVT
Net Income 11.08M -1.39M VTVT
Net Margin 30.1% -94.5% VTVT
Operating Income 9.33M -1.47M VTVT
ROE 14.1% -22.8% VTVT
ROA 12.6% -19.9% VTVT
Total Assets 87.59M 6.97M VTVT
Current Ratio 12.48 7.43 VTVT

Relative Price Performance (Last 90 Days)

XBIO 1M: +18.2% · 3M: +30.0% VTVT 1M: +0.6% · 3M: +1.2%

Current Technical Phase

XBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.0% over 20 days), RSI 54

RSI (14): 53.7 · Price: $3.90

VTVT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.6%) with fading momentum, RSI 45

RSI (14): 45.0 · Price: $31.97

Fundamentals Snapshot

Metric XBIO VTVT
Market Cap
Forward P/E -11.5 -7.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 1.0% 0.2%
Operating Margin -1.5% -0.3%
EPS -1.15 -0.75
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VTVT is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.